Negative Currency Effects Hit Bio-Rad's Q2 Revenues, but Shares Rise | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its second-quarter revenues declined nearly 6 percent but were up almost 4 percent on a currency-neutral basis compared to the second quarter of 2008.

The Hercules, Calif.-based firm generated total revenues of $427.2 million for the three-month period ended June 30, compared to $452.4 million the year before. Its life science segment had revenue of $149.7 million, down 7 percent year over year, while its clinical diagnostics segment was down nearly 5 percent to $274.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.